Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland.
Panje CM, Lupatsch JE, Barbier M, Pardo E, Lorez M, Dedes KJ, Aebersold DM, Plasswilm L, Gautschi O, Schwenkglenks M; Swiss Group for Clinical Cancer Research (SAKK). Panje CM, et al. Ann Oncol. 2020 Apr;31(4):501-506. doi: 10.1016/j.annonc.2020.01.007. Epub 2020 Jan 16. Ann Oncol. 2020. PMID: 32107097 Free article.
Objective consensus from decision trees.
Putora PM, Panje CM, Papachristofilou A, Dal Pra A, Hundsberger T, Plasswilm L. Putora PM, et al. Among authors: panje cm. Radiat Oncol. 2014 Dec 5;9:270. doi: 10.1186/s13014-014-0270-y. Radiat Oncol. 2014. PMID: 25476988 Free PMC article.
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC).
Panje CM, Dedes KJ, Matter-Walstra K, Schwenkglenks M, Gautschi O, Siano M, Aebersold DM, Plasswilm L, Lupatsch JE; Swiss Group for Clinical Cancer Research (SAKK). Panje CM, et al. Radiother Oncol. 2018 Nov;129(2):257-263. doi: 10.1016/j.radonc.2018.07.017. Epub 2018 Aug 10. Radiother Oncol. 2018. PMID: 30104008 Clinical Trial.
Cost-effectiveness of nivolumab in the treatment of head and neck cancer.
Hirschmann A, Lupatsch JE, Schwenkglenks M, Panje CM, Matter-Walstra K, Espeli V, Dedes KJ, Siano M; Swiss Group of Clinical Cancer Research (SAKK). Hirschmann A, et al. Among authors: panje cm. Oral Oncol. 2018 Dec;87:104-110. doi: 10.1016/j.oraloncology.2018.10.032. Epub 2018 Oct 30. Oral Oncol. 2018. PMID: 30527224
Treatment Options in Oncology.
Panje CM, Glatzer M, Sirén C, Plasswilm L, Putora PM. Panje CM, et al. JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.18.00017. JCO Clin Cancer Inform. 2018. PMID: 30652608 Free article. Review.
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM, Höng L, Hayoz S, Baracos VE, Herrmann E, Garcia Schüler H, Meier UR, Henke G, Schacher S, Hawle H, Gérard MA, Ruhstaller T, Plasswilm L; Swiss Group for Clinical Cancer Research (SAKK). Panje CM, et al. Radiat Oncol. 2019 Sep 11;14(1):166. doi: 10.1186/s13014-019-1372-3. Radiat Oncol. 2019. PMID: 31511012 Free PMC article. Clinical Trial.
39 results